HealthCor Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-229,530
| Closed | -$14.2M | – | 65 |
|
2022
Q3 | $14.2M | Sell |
229,530
-674,320
| -75% | -$41.7M | 1.78% | 24 |
|
2022
Q2 | $72.1M | Buy |
903,850
+193,740
| +27% | +$15.5M | 7.24% | 2 |
|
2022
Q1 | $74.7M | Sell |
710,110
-122,160
| -15% | -$12.9M | 4.98% | 3 |
|
2021
Q4 | $89.7M | Sell |
832,270
-445,958
| -35% | -$48.1M | 4.88% | 4 |
|
2021
Q3 | $140M | Buy |
1,278,228
+43,180
| +3% | +$4.73M | 6.04% | 2 |
|
2021
Q2 | $116M | Sell |
1,235,048
-490,602
| -28% | -$45.9M | 4.62% | 3 |
|
2021
Q1 | $159M | Sell |
1,725,650
-392,440
| -19% | -$36.1M | 5.62% | 1 |
|
2020
Q4 | $155M | Buy |
2,118,090
+327,780
| +18% | +$24M | 5.98% | 1 |
|
2020
Q3 | $139M | Buy |
1,790,310
+1,389,270
| +346% | +$108M | 5.57% | 4 |
|
2020
Q2 | $22.3M | Sell |
401,040
-393,440
| -50% | -$21.9M | 0.93% | 32 |
|
2020
Q1 | $23.5M | Buy |
+794,480
| New | +$23.5M | 1.01% | 28 |
|
2019
Q4 | – | Sell |
-2,628,840
| Closed | -$71.6M | – | 73 |
|
2019
Q3 | $71.6M | Sell |
2,628,840
-164,830
| -6% | -$4.49M | 2.71% | 15 |
|
2019
Q2 | $67.2M | Buy |
2,793,670
+802,341
| +40% | +$19.3M | 2.61% | 13 |
|
2019
Q1 | $52.6M | Buy |
+1,991,329
| New | +$52.6M | 2.13% | 19 |
|
2016
Q4 | – | Sell |
-4,250,000
| Closed | -$77.1M | – | 51 |
|
2016
Q3 | $77.1M | Buy |
+4,250,000
| New | +$77.1M | 4.7% | 7 |
|
2015
Q3 | – | Sell |
-3,200,000
| Closed | -$111M | – | 59 |
|
2015
Q2 | $111M | Sell |
3,200,000
-800,000
| -20% | -$27.8M | 5.6% | 4 |
|
2015
Q1 | $104M | Sell |
4,000,000
-1,600,000
| -29% | -$41.6M | 4.96% | 1 |
|
2014
Q4 | $72.2M | Buy |
5,600,000
+2,025,000
| +57% | +$26.1M | 4.02% | 5 |
|
2014
Q3 | $43.9M | Buy |
3,575,000
+875,000
| +32% | +$10.7M | 2.25% | 18 |
|
2014
Q2 | $42.7M | Buy |
+2,700,000
| New | +$42.7M | 2.14% | 21 |
|